Picture of Vitrolife AB logo

VITR — Vitrolife AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Vitrolife Q3 EBITDA Rises To SEK 162 Mln

Oct 29 (Reuters) - Vitrolife AB  VITR.ST :
    * INTERIM REPORT JANUARY - SEPTEMBER 2021: PROFITABLE GROWTH
AND
IGENOMIX ACQUISITION
    * Q3 SALES AMOUNTED TO SEK 406 (320) MILLION, CORRESPONDING
TO AN
INCREASE OF 27 PERCENT IN SEK. SALES INCREASED BY 30 PERCENT IN
LOCAL CURRENCY.
    * Q3 OPERATING INCOME BEFORE DEPRECIATION AND AMORTISATION
(EBITDA) AMOUNTED TO SEK 162 (134) MILLION
    * Q3 NET INCOME AMOUNTED TO SEK 105 (89) MILLION, WHICH GAVE
EARNINGS PER SHARE OF SEK 0.89 (0.81)

Source text for Eikon:  ID:nWkr5dSYZJ 
Further company coverage:  VITR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Vitrolife AB

See all news